问鼎娱乐.com|极速飞艇的冠亚和计划|极速赛车计划群群名|sg幸运飞艇计划官方版下载

<label id="6kt4j"></label>

    <li id="6kt4j"></li>
        1. Recombinant Human sTRAILR2/TNFRSF10B Protein

          更多活動更多優(yōu)惠,盡在翌圣商城》

          批量采購, 請點(diǎn)擊詢價(jià)

          產(chǎn)品說明書

          FAQ

          COA

          已發(fā)表文獻(xiàn)

          TRAIL Receptor-1/DR4 and TRAIL Receptor-2/DR5 belong to the TNFR superfamily of transmembrane proteins, and contain a cytoplasmic "death domain," which can activate the cell's apoptotic machinery. These receptors are activated by binding to either membrane-anchored or soluble TRAIL/Apo2L. The DR4 and DR5 receptors are both produced as type I transmembrane proteins, which contain an extracellular domain, a transmembrane domain, and a cytoplasmic domain. The recombinant soluble forms of DR4 and DR5 consist of the TNFR-homologous, cysteine-rich portion of their respective extracellular domains. Recombinant Human soluble TRAIL Receptor-2/DR5 is a 14.9 kDa protein (133 amino acid residues) consisting of the TNFR-homologous, cysteine-rich portion of the extracellular domain.

           

          Product Properties

          Synonyms

          soluble TRAIL Receptor-2, DR5, TNFRSF10B, KILER, TRICK2A, TRICKB

          Accession

          O14763

          GeneID

          8795

          Source

          E.coli-derived Human soluble TRAIL Receptor-2 protein,Glu52-Ser183.

          Molecular Weight

          Approximately 14.8 kDa

          AA Sequence

          ESALITQQDL APQQRAAPQQ KRSSPSEGLC PPGHHISEDG RDCISCKYGQ DYSTHWNDLL FCLRCTRCDS GEVELSPCTT TRNTVCQCEE GTFREEDSPE MCRKCRTGCP RGMVKVGDCT PWSDIECVHK ES

          Tag

          None

          Physical Appearance

          Sterile Filtered White lyophilized (freeze-dried) powder.

          Purity

          > 97 % by SDS-PAGE and HPLC analyses.

          Biological Activity

          Fully biologically active when compared to standard. rHusTRAIL-R2 reduced the production of LPS-induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/mL) but in the presence of rHusTRAIL-R2, TRAIL-induced TNF is suppressed.

          Endotoxin

          < 1.0 EU per 1μg of the protein by the LAL method.

          Formulation

          Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.

          Reconstitution

          We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

           

          Shipping and Storage

          The products are shipped with ice pack and can be stored at -20 for 1 year.

          1 month, 2 to 8 °C under sterile conditions after reconstitution.

          3 months, -20 °C under sterile conditions after reconstitution.

          Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

           

          Cautions

          1.Avoid repeated freeze-thaw cycles.

          2.For your safety and health, please wear lab coats and disposable gloves for operation.

          3.For research use only.

          HB221028

          400-6111-883